OMCL
HealthcareOmnicell, Inc.
$46.93
+$1.79 (+3.97%)
Jan 5, 2026
Price History (1Y)
Analysis
Omnicell, Inc. is a healthcare company based in the United States, operating within the Health Information Services industry under the Healthcare sector. With a market capitalization of $2.16B and annual revenue of $1.18B, the company has a significant presence in its field. Omnicell employs approximately 3600 individuals. The company's financial health is characterized by moderate profitability, with gross margin at 43.8%, operating margin at 2.7%, and profit margin at 1.7%. Returns on equity (ROE) stand at 1.6% and returns on assets (ROA) are 0.5%. Omnicell's balance sheet shows a debt-to-equity ratio of 16.94, indicating significant reliance on debt financing. The company maintains a current ratio of 1.45, suggesting it has sufficient liquidity to meet its short-term obligations. Omnicell's valuation context is influenced by its price-to-earnings (P/E) ratios of 104.29 and 25.45 for the trailing twelve months and forward periods, respectively. The company's revenue growth rate over the past year stands at 10.0%, while earnings growth has declined by 35.9% over the same period. Omnicell does not distribute dividends to shareholders, with a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Visit website →Key Statistics
- Market Cap
- $2.16B
- P/E Ratio
- 104.29
- 52-Week High
- $47.69
- 52-Week Low
- $22.66
- Avg Volume
- 490.52K
- Beta
- 0.78
Company Info
- Industry
- Health Information Services
- Exchange
- NMS
- Country
- United States
- Employees
- 3,600